🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of or...
Status
Completed
Location
Mayo Clinic Scottsdale Recruiting
Start Date
2011-06
Trial ID
NCT01423851
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
Phase II study to assess the efficacy of 6 cycles of oral JAK1/2 inhibitor ...
Status
Completed
Location
UCL Louvain St Luc
Start Date
2013-07-04
Trial ID
NCT01877005
Treatments Being Tested
This is a phase I study of TQ05105 tablets in subjects with Hemophagocytic ...
Status
Unknown
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2020-07-17
Trial ID
NCT04326348
Treatments Being Tested
The purpose of this study was to determine clinical efficacy and safety of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00639002
Treatments Being Tested
This is a phase Ib study with the primary purpose is to estimate the MTD an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-05-21
Trial ID
NCT02370706
Treatments Being Tested
TQ05105 is a JAK2 inhibitors and can be used to treat JAK2 target-related d...
Status
Completed
Location
West China Hospital ,Sichuan University
Start Date
2018-11-20
Trial ID
NCT04339400
Treatments Being Tested
The goal of this clinical trial is to learn which of three different doses ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11
Trial ID
NCT07750574
Treatments Being Tested
This is a global, multicenter, 2-part study to evaluate the efficacy and sa...
Status
Active Not Recruiting
Location
UAB Division of Hematology/Oncology
Start Date
2021-03-11
Trial ID
NCT04562389
Treatments Being Tested
TQ05105 is a class 1 new drug with a new chemical structure developed by Ch...
Status
Completed
Location
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Start Date
2021-07-19
Trial ID
NCT05982106
Treatments Being Tested